Prostate Cancer Drug Creator ICR Sees 6-Week Research Strike Threaten Breakthroughs
The industrial action at the Institute of Cancer Research, originator of Abiraterone, has halted lab work for six weeks and counting, jeopardizing cancer clinical trials and scientific momentum.
Source: yorkpress.co.uk · timesandstar.co.uk